TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11488741

Group type: EXPERIMENTAL
Intervention: Hypospadias objective scoring evaluation (HOSE) system
Number of subjects: 20
Study: 9707027

Group type: EXPERIMENTAL
Intervention: Chemotherapy only (chemo)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Chemotherapy and total body irradiation (chemo + TBI)
Number of subjects: 122
Study: 7837149

Group type: EXPERIMENTAL
Intervention: CREST syndrome
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Diffuse scleroderma
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 34
Study: 3349312

Group type: EXPERIMENTAL
Intervention: Wedge resection/segmental phenolization combination treatment (WR/SP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Wedge resection (WR)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Segmental phenolization (SP)
Number of subjects: 140
Study: 31629355

Group type: EXPERIMENTAL
Intervention: Center-Based Exercise Program (CB)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Home and Center-Based Exercise Program (H+CB)
Number of subjects: 25
Study: 30041703

Group type: EXPERIMENTAL
Intervention: Physician-delivered Motivational Interviewing (MI) intervention
Number of subjects: 420

Group type: COMPARATOR
Intervention: Physician Standard of Care (Control)
Number of subjects: 420
Study: 28561039

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combined strength + endurance training
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Physical activity recommendations
Number of subjects: 89
Study: 26286872

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.5 mg/kg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Chloral hydrate syrup (50 mg/kg)
Number of subjects: 82
Study: 24185540

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 70
Study: 19778920

Group type: EXPERIMENTAL
Intervention: Culprit vessel angioplasty-only (COR group)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Staged revascularisation (SR group)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Simultaneous treatment of non-IRA (CR group)
Number of subjects: 263
Study: 19055715

Group type: EXPERIMENTAL
Intervention: Direct feeding on gametocyte carriers
Number of subjects: 372

Group type: COMPARATOR
Intervention: Membrane feeding method
Number of subjects: 372
Study: 16800995

Group type: EXPERIMENTAL
Intervention: Shengxuening and cyclosporin A (CsA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Androgen alone
Number of subjects: 45
Study: 14525815

Group type: EXPERIMENTAL
Intervention: Piroxicam gel
Number of subjects: 10

Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 10
Study: 11093050

Group type: EXPERIMENTAL
Intervention: Combined analysis of plasma sCD26 and sCD30
Number of subjects: 0
Study: 8841153

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (25 mg/16 hr) during sauna session
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (no sauna)
Number of subjects: 12
Study: 1642129

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 150 mg per day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 6839004

Group type: COMPARATOR
Intervention: Atenolol (100 mg single oral dose)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Metoprolol (100 mg single oral dose)
Number of subjects: 6
Study: 31558376

Group type: COMPARATOR
Intervention: Single dose of ivermectin 200 μg/kg
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Four doses of ivermectin 200 μg/kg (given on days 1, 2, 15, and 16)
Number of subjects: 309
Study: 29314659

Group type: EXPERIMENTAL
Intervention: Multi-layer polyurethane foam dressing (ALLEVYN LIFE™)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 359
Study: 26854246

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg daily)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 24280344

Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg/day) for 6 months
Number of subjects: 30
Study: 22880097

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 30
Study: 20956902

Group type: EXPERIMENTAL
Intervention: 2.5 mg midazolam with 0.5% hyperbaric bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% hyperbaric bupivacaine with 5% dextrose in aqua
Number of subjects: 60
Study: 17959979

Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (ITS)
Number of subjects: 1305

Group type: COMPARATOR
Intervention: Morphine IV PCA
Number of subjects: 1305
Study: 16277588

Group type: EXPERIMENTAL
Intervention: Mechanical and chemical oral cleansing using povidone-iodine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Professional oral health care (POHC) administered by dental hygienists once a week for 24 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: POHC treatment for 6 months in the winter season
Number of subjects: 0
Study: 16406170

Group type: EXPERIMENTAL
Intervention: HPIV3cp45 vaccine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 10828084

Group type: EXPERIMENTAL
Intervention: Low dose GH (1 U daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High dose GH (2 U daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High dose GH (after 12 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8657857

Group type: EXPERIMENTAL
Intervention: Individual therapy with relaxation therapy and autogenic training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Group therapy with relaxation therapy and autogenic training
Number of subjects: 42
Study: 1505610

Group type: EXPERIMENTAL
Intervention: 16-hour nicotine patch releasing 15 mg nicotine applied daily for 16 h over 12 weeks
Number of subjects: 167
Study: 6345370

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg three times daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg three times daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg three times daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29438562

Group type: EXPERIMENTAL
Intervention: Tdap vaccine (n = 1002)
Number of subjects: 1330

Group type: COMPARATOR
Intervention: Td vaccine (n = 328)
Number of subjects: 1330
Study: 30242825

Group type: EXPERIMENTAL
Intervention: 2.5 mg nebulized salbutamol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5 mg nebulized salbutamol
Number of subjects: 50
Study: 26286298

Group type: EXPERIMENTAL
Intervention: Intervention group (parents taught healthy lifestyles)
Number of subjects: 305
Study: 26305442

Group type: EXPERIMENTAL
Intervention: Classroom Communication Resource (CCR) intervention administered to 97 participants in the experimental group.
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (114 participants) did not receive the CCR intervention.
Number of subjects: 211
Study: 22510052

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services with follow-up visit requirement
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services with lower infection rate
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services with less pain
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services with private waiting room
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services explaining risks and benefits
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Community-based male circumcision services requiring an HIV test
Number of subjects: 645
Study: 20118780

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (hemoglobin threshold of 7.0 g/dL)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (hemoglobin threshold of 9.5 g/dL)
Number of subjects: 124
Study: 19094597

Group type: EXPERIMENTAL
Intervention: PHRAIC group
Number of subjects: 509

Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 509
Study: 15925966

Group type: EXPERIMENTAL
Intervention: Acute scapholunate dissociation (SLD) detected in patients with distal radius fractures
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chronic scapholunate dissociation (SLD)
Number of subjects: 120
Study: 12401733

Group type: EXPERIMENTAL
Intervention: 400 IU vitamin E daily
Number of subjects: 3654

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3654
Study: 10064663

Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg 4 times daily for 2 weeks)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (for 2 weeks)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 29873776

Group type: EXPERIMENTAL
Intervention: School lunch program (10 percentage point increase in coverage rate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: School lunch program
Number of subjects: 0
Study: 29273477

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (Hb < 7.5 g/dL)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (Hb < 9.5 g/dL intraoperatively or postoperatively in ICU; Hb < 8.5 g/dL on the ward)
Number of subjects: 5000
Study: 26272784

Group type: EXPERIMENTAL
Intervention: Higher stress levels
Number of subjects: 2
Study: 25493193

Group type: EXPERIMENTAL
Intervention: L-tug lycosome formulation of dark chocolate (30 g daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Regular dark chocolate (30 g daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dark chocolate with 7 mg of lycopene
Number of subjects: 29
Study: 22516310

Group type: EXPERIMENTAL
Intervention: Celecoxib (200mg twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19653741

Group type: EXPERIMENTAL
Intervention: Luminous spot moving in the dark at varying speeds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in direction of successive motion vectors
Number of subjects: 0
Study: 17589978

Group type: EXPERIMENTAL
Intervention: Stent graft
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sirolimus eluting stent
Number of subjects: 119

Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 119
Study: 15206992

Group type: EXPERIMENTAL
Intervention: Tetracycline (500 mg 12 hourly for 7 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Halofantrine alone
Number of subjects: 8
Study: 11507213

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV recombinant canarypox vaccines
Number of subjects: 291
Study: 9674400

Group type: EXPERIMENTAL
Intervention: Rapidly shaking and pinching the skin during lidocaine injection
Number of subjects: 103

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 103
Study: 8018904

Group type: EXPERIMENTAL
Intervention: MCNU-VMP therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: VMP therapy
Number of subjects: 99
Study: 2659132

Group type: EXPERIMENTAL
Intervention: Trimethoprim + sulphamethoxazole or mecillinam (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methenamine hippurate (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (Group C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group B + C
Number of subjects: 0
Study: 162677

Group type: EXPERIMENTAL
Intervention: Viloxazine (150 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viloxazine with tranquillizer (perphenazine or diazepam)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam (15 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31701698

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 29
Study: 31403688

Group type: EXPERIMENTAL
Intervention: Text messaging engagement with support persons
Number of subjects: 123

Group type: COMPARATOR
Intervention: Participants who did not invite a support person
Number of subjects: 123
Study: 29126292

Group type: EXPERIMENTAL
Intervention: ZVIN (4 doses)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 25762120

Group type: EXPERIMENTAL
Intervention: Video clips that elicited laughter and positive affect
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 0
Study: 22767271

Group type: EXPERIMENTAL
Intervention: Individually tailored booster intervention
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Middle-term booster (67-94 days)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Control booster
Number of subjects: 403

Group type: COMPARATOR
Intervention: No booster
Number of subjects: 403
Study: 21703879

Group type: EXPERIMENTAL
Intervention: Anti-gravity treadmill (AG) at 85% body weight
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no AG treadmill)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison of AG and control groups
Number of subjects: 16
Study: 18972832

Group type: EXPERIMENTAL
Intervention: Reference formulation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Test formulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-administration (control)
Number of subjects: 24
Study: 16801664

Group type: EXPERIMENTAL
Intervention: Newcastle Mitochondrial Disease Adult Scale
Number of subjects: 0
Study: 12707557

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Combination of fluoxetine and cognitive-behavioral therapy
Number of subjects: 432

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 432
Study: 11055000

Group type: EXPERIMENTAL
Intervention: Curative radiofrequency ablation in patients over 70 years (Group II)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Curative radiofrequency ablation in patients under 70 years (Group I)
Number of subjects: 178
Study: 8648982

Group type: EXPERIMENTAL
Intervention: Measurements at the retina
Number of subjects: 10

Group type: COMPARATOR
Intervention: Measurements at the pupil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Observations at the retina for small bubbles up to 4 dd above the disc
Number of subjects: 10
Study: 1534422

Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg or 800 mg single oral dose)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Ceftriaxone (250 mg single intramuscular dose)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 187

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 187
Study: 6378988

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg q.i.d. per os)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metoprolol (100 mg b.i.d. per os)
Number of subjects: 20
Study: 28948440

Group type: EXPERIMENTAL
Intervention: Intrauterine hCG infusion prior to embryo transfer (ET)
Number of subjects: 458

Group type: COMPARATOR
Intervention: No hCG infusion prior to embryo transfer (ET)
Number of subjects: 458
Study: 26681752

Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Combination therapy (atorvastatin/niacin)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Statin therapy (Atorvastatin)
Number of subjects: 126
Study: 24375159

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg three times daily for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (3 tablets/day) for 2 months
Number of subjects: 40
Study: 23006975

Group type: EXPERIMENTAL
Intervention: Structured brief advice and referral for a 20-minute motivational interviewing session with an alcohol health worker
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 120
Study: 20668668

Group type: EXPERIMENTAL
Intervention: M01ZH09 (5x10^9 CFU)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 18616783

Group type: EXPERIMENTAL
Intervention: Moisturizer A
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moisturizer B
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moisturizer C
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no moisturizer)
Number of subjects: 14
Study: 15068495

Group type: EXPERIMENTAL
Intervention: Clodronate 800 mg daily
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study: 12059895

Group type: EXPERIMENTAL
Intervention: Propofol (Group P, bolus 1.5-2.0 mg/kg, maintenance 3.0-7.0 mg/kg/h) with remifentanil (10 microg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane (Group S, inhalational induction, end-tidal concentration 0.7-1.2 vol.%) with remifentanil (10 microg/kg/h)
Number of subjects: 40
Study: 9524891

Group type: EXPERIMENTAL
Intervention: Simethicone
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 8562234

Group type: EXPERIMENTAL
Intervention: Metoprolol 6.25 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Celiprolol 25 mg daily
Number of subjects: 20
Study: 2748256

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 668553

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g daily for 4 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg daily long-term)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 78
Study: 31923768

Group type: EXPERIMENTAL
Intervention: Metoprolol 25 mg and Aspirin 100 mg
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 30661564

Group type: EXPERIMENTAL
Intervention: Personalized Feedback Intervention (PFI)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Assessment Only (AO)
Number of subjects: 198
Study: 30072210

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26908915

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 122
Study: 25428268

Group type: EXPERIMENTAL
Intervention: Usual care plus lightweight fibreglass heel casts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study: 23577699

Group type: EXPERIMENTAL
Intervention: Morphine-induced postconditioning (0.1 mg/kg)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 89
Study: 20078390

Group type: EXPERIMENTAL
Intervention: MNC+G-CSF
Number of subjects: 15

Group type: COMPARATOR
Intervention: MNC-G-CSF
Number of subjects: 15
Study: 18851797

Group type: EXPERIMENTAL
Intervention: Bone morphogenetic proteins (BMPs)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gold standard methods of autografting
Number of subjects: 30
Study: 16816833

Group type: EXPERIMENTAL
Intervention: Day/Night dissociated formula milk
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard formula milk (control)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Inverse control (Night/Day formula)
Number of subjects: 21
Study: 12730559

Group type: EXPERIMENTAL
Intervention: Intermediate anticoagulation regimen (INR 2.0 to 3.0)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10741625

Group type: EXPERIMENTAL
Intervention: Bolus injection of 2 g cefpirome
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 2 g cefpirome over 8 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefpirome
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bolus injection and continuous infusion of cefpirome
Number of subjects: 12
Study: 8841652

Group type: EXPERIMENTAL
Intervention: Disulfiram for alcohol cessation
Number of subjects: 0
Study: 1392754

Group type: EXPERIMENTAL
Intervention: Amitriptyline prescribed by a psychiatrist
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy from a clinical psychologist
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Counselling and case work by a social worker
Number of subjects: 121

Group type: COMPARATOR
Intervention: Routine care by a general practitioner
Number of subjects: 121
Study: 2951093

Group type: EXPERIMENTAL
Intervention: Bread (90 g)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Spaghetti (65 g)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Potatoes (285 g)
Number of subjects: 7
Study: 31752769

Group type: EXPERIMENTAL
Intervention: Anti-VEGF monotherapy
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Initial combination therapy (PDT + anti-VEGF)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Deferred combination therapy (PDT + anti-VEGF)
Number of subjects: 46
Study: 30286595

Group type: EXPERIMENTAL
Intervention: Promotora-led physical activity intervention
Number of subjects: 614
Study: 27227384

Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol HFA pMDI
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reference product (fluticasone/salmeterol HFA pMDI)
Number of subjects: 16
Study: 24457901

Group type: EXPERIMENTAL
Intervention: Successful smoking cessation
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Unsuccessful smoking cessation
Number of subjects: 192
Study: 22949147

Group type: EXPERIMENTAL
Intervention: Aflibercept (4 mg/kg intravenously) plus FOLFIRI
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Placebo plus FOLFIRI
Number of subjects: 1226
Study: 20012199

Group type: EXPERIMENTAL
Intervention: Project ALERT curriculum (11 core lessons for sixth graders and 3 booster lessons for seventh graders)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Project ALERT curriculum
Number of subjects: 34
Study: 18586927

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (6.75 microg/kg) every 4 weeks
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo every 4 weeks
Number of subjects: 218